PLANNING CONTROLLED CLINICAL-TRIALS ON THE BASIS OF DESCRIPTIVE DATA-ANALYSIS

In controlled clinical trials the problem of multiplicity of desired inferential statements finds attention at an increasing rate. In this paper the previously proposed concept of Descriptive Data Analysis (DDA), situated between Confirmatory and Exploratory Data Analysis, is applied to the planning aspects of controlled trials for which the problem of multiplicity exists. The (non-Bayesian) DDA planning concept should provide the investigator with tools to draw final conclusions from data of several variables possibly observed at several time points in possibly several groups of subjects by combining his pre-trial medical experience with descriptive inferential statements (confidence intervals and test results) at nominal significance levels. DDA also provides for confirmatory statements concerning individual null hypothesis and partially global hypotheses.